Greek health reports revealed that pharmaceutical giant Moderna has announced it is developing a vaccine related to a disease that recently drew attention after cases were detected on a cruise ship. According to infectious disease specialist Chantaios, the company had begun its research “well before the cases on the cruise ship” emerged. No further details on the specific pathogen were included, but the announcement adds to a pattern of pharmaceutical firms accelerating vaccine pipelines in response to emerging infectious threats.
Meanwhile, Greece was grappling with a severe episode of African dust blanketing the country. Experts urged citizens — particularly vulnerable groups — to limit outdoor movement and avoid physical exercise outside, warning of respiratory problems and irritation from elevated particulate levels in the atmosphere.
